Bain Capital Life Sciences Investors, LLC Cti Biopharma Corp Transaction History

Bain Capital Life Sciences Investors, LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2023 May 15, 2023	BUY	$4.2 - $6.01 $3.89 Million - $5.56 Million	925,688 Added 24.51%	4,702,996 $19.8 Million
Q4 2022 Feb 14, 2023	BUY	$4.45 - $6.17 $16.8 Million - $23.3 Million	3,777,308 New	3,777,308 $22.7 Million

Ticker CTIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 114,385,000
Market Cap $1.04B
Description
CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients w...

Get notified when there are updates to the investment portfolio of Bain Capital Life Sciences Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Bain Capital Life Sciences Investors, LLC with notifications on news.